A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation

Bernd Krüger, Bernd Schröppel, Rami Ashkan, Brad Marder, Carl Zülke, Barbara Murphy, Bernhard K. Krämer, Michael Fischereder

Research output: Contribution to journalArticlepeer-review

96 Scopus citations


Among the factors modulating transplant rejection and cardiovascular disease, chemokines and their respective receptors deserve special attention. In this respect, increased expression of MCP-1 and the corresponding receptor CCR2 have been demonstrated in renal transplant rejection and coronary artery disease. The impact of the MCP-1-2518G and CCR2-64I genotypes on renal allograft function was investigated in 232 patients who underwent transplantation over an 11-yr period. Genomic DNA was genotyped using PCR with sequence-specific primers followed by restriction fragment length polymorphism analysis. Eighteen (7.8%) patients were homozygous for the MCP-1-2518G mutation. The G/G allele of MCP-1-2518 behaved as a determinant for long-term allograft survival and resulted in reduction of the mean graft survival, as compared with the heterozygous (A/G) or wild-type (A/A) allele (67 ± 14 versus 95 ± 4 mo; Log rank P = 0.0052). The 64I mutation of CCR2 had no effect on kidney graft failure (93 ± 6 and 91 ± 5 mo, respectively; P = 0.81). None of the investigated polymorphisms showed a significant shift in gene frequency in acute rejection and rejection-free groups. In conjunction with these findings, peripheral blood mononuclear cells from kidney transplant recipients carrying the G-allele were characterized by a 2.5-fold higher MCP-1 secretion (P < 0.05). In conclusion, recipients of renal transplants homozygous for the -2518 G mutation of the MCP-1 gene are at risk for premature kidney graft failure. This variant of MCP-1 may be a future predictor for long-term kidney graft failure.

Original languageEnglish
Pages (from-to)2585-2589
Number of pages5
JournalJournal of the American Society of Nephrology : JASN
Issue number10
StatePublished - 1 Oct 2002


Dive into the research topics of 'A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation'. Together they form a unique fingerprint.

Cite this